First-line treatment with abciximab does not reduce mortality or myocardial infarction in people with acute coronary syndromes not undergoing early revascularization

✍ Scribed by Christopher P Cannon

• Book ID: 119763757
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 238 KB
• Volume: 5
• Category: Article
• ISSN: 1361-2611
• DOI: 10.1054/ebcm.2001.0418